KIAA0226 (KIAA0226) Peptide
-
- Target See all Rubicon (KIAA0226) products
- Rubicon (KIAA0226) (KIAA0226)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DQEGGGESQL SSVLRRSSFS EGQTLTVTSG AKKSHIRSHS DTSIASRGAP
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA0226 antibody,
Alternative Names: KIAA0226 control peptide, KIAA0226 antibody Blocking Peptide, Anti-KIAA0226 Blocking Peptide, KIAA0226 Blocking Peptide, KIAA0226, KIAA0-226, KIAA0 226, KIAA0-226 Blocking Peptide, KIAA0 226 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Rubicon (KIAA0226) (KIAA0226)
- Background
- KIAA0226 negatively regulates endocytic trafficking. KIAA0226 impairs the autophagosome maturation process.KIAA0226 may inhibit PIK3C3 activity.
- Molecular Weight
- 103 kDa
-